On 09-mar-2021, abbott point of care was contacted by a customer regarding i-stat cg8+ cartridges that yielded a suspected discrepant hematocrit result on an (b)(6) year old male patient post fall from ladder; complaint of pain to right side body.There was no additional patient information available at the time of this report.Return product is not available for investigation.Analyzer: lab.Date: (b)(6) 2021.Collected/tested: 11:40am/12:09pm, 41% pcv.Hematocrit : 13.3 g/l.Hemoglobin: 218 mg/dl.Glucose:.Analyzer: i-stat.Date: (b)(6)2021.Collected/tested: 11:59am/11:59pm, 17% pcv.Hematocrit : 5.8 g/dl.Hemoglobin: 158 mg/dl.Glucose:.There are no injuries associated with this event.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on limited information available that suggests the product was not performing within the variability of the assay.The patient was transfused 2 units prbcs (660mls) at 11:54 am.The customer stated that the patient was transfused based only upon the patient condition.The investigation is underway.
|
Apoc incident: # (b)(4).The investigation was completed on 08-jun-2021.The customer reported obtaining a discrepancy in glu, hct and hgb patient sample results between i-stat cg8+ cartridge lot w20351a and the lab instrument.A review of the device history record confirmed the cartridge lot met finished goods release criteria.A deficiency has been determined for cg8+ cartridge lot w20351a as retained testing did not meet the acceptance criteria found in (b)(4) rev.Af, appendix 1 - product complaint level 2 and level 3 investigation procedure for rate of ica results outside of total allowable error.This deficiency will be investigated under quality record (qr) (b)(4).
|